(Q38940345)
Statements
1 reference
Preclinical Evidence for the Therapeutic Potential of CD38-Targeted Immuno-Chemotherapy in Multiple Myeloma Patients Refractory to Lenalidomide and Bortezomib (English)
1 reference
Niels W C J van de Donk
Tuna Mutis
Inger S Nijhof
Willy A Noort
Berris van Kessel
Regina de Jong-Korlaar
Joost Bakker
Jeroen J L van Bueren
Anton C M Martens
14 November 2014
1 reference